questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Protéines et peptides de signalisation intracellulaire
Protein-Serine-Threonine Kinases
Cyclic Nucleotide-Regulated Protein Kinases
Cyclic GMP-Dependent Protein Kinases
Cyclic GMP-Dependent Protein Kinases : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
GMP cyclique
Tests de laboratoire
Kinases
Essais enzymatiques
Symptômes
5
Troubles neurologiques
Kinases
Fonction cardiaque
Kinases
Maladies cardiovasculaires
Kinases
Troubles de l'humeur
Kinases
Traitements
5
Thérapies géniques
Kinases
Plantes médicinales
Kinases
Complications
5
Troubles de la coagulation
Kinases
Troubles respiratoires
Kinases
Facteurs de risque
5
Facteurs de risque
Kinases
Antécédents familiaux
Kinases
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Cyclic GMP-Dependent Protein Kinases : Questions médicales les plus fréquentes",
"headline": "Cyclic GMP-Dependent Protein Kinases : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Cyclic GMP-Dependent Protein Kinases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-11",
"dateModified": "2025-04-06",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Cyclic GMP-Dependent Protein Kinases"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Cyclic Nucleotide-Regulated Protein Kinases",
"url": "https://questionsmedicales.fr/mesh/D017867",
"about": {
"@type": "MedicalCondition",
"name": "Cyclic Nucleotide-Regulated Protein Kinases",
"code": {
"@type": "MedicalCode",
"code": "D017867",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.563.150"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Cyclic GMP-dependent protein kinase type I",
"alternateName": "Cyclic GMP-Dependent Protein Kinase Type I",
"url": "https://questionsmedicales.fr/mesh/D062965",
"about": {
"@type": "MedicalCondition",
"name": "Cyclic GMP-dependent protein kinase type I",
"code": {
"@type": "MedicalCode",
"code": "D062965",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.563.150.150.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cyclic GMP-dependent protein kinase type II",
"alternateName": "Cyclic GMP-Dependent Protein Kinase Type II",
"url": "https://questionsmedicales.fr/mesh/D062967",
"about": {
"@type": "MedicalCondition",
"name": "Cyclic GMP-dependent protein kinase type II",
"code": {
"@type": "MedicalCode",
"code": "D062967",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.563.150.150.750"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Cyclic GMP-Dependent Protein Kinases",
"alternateName": "Cyclic GMP-Dependent Protein Kinases",
"code": {
"@type": "MedicalCode",
"code": "D017869",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Fengyang Li",
"url": "https://questionsmedicales.fr/author/Fengyang%20Li",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Ute Römling",
"url": "https://questionsmedicales.fr/author/Ute%20R%C3%B6mling",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Stepan Gambaryan",
"url": "https://questionsmedicales.fr/author/Stepan%20Gambaryan",
"affiliation": {
"@type": "Organization",
"name": "Sechenov Institute of Evolutionary Physiology and Biochemistry of the Russian Academy of Sciences, Saint Petersburg 194223, Russia."
}
},
{
"@type": "Person",
"name": "Roshni R Kharadi",
"url": "https://questionsmedicales.fr/author/Roshni%20R%20Kharadi",
"affiliation": {
"@type": "Organization",
"name": "Department of Plant, Soil and Microbial Sciences, Michigan State University, East Lansing, Michigan, USA."
}
},
{
"@type": "Person",
"name": "George W Sundin",
"url": "https://questionsmedicales.fr/author/George%20W%20Sundin",
"affiliation": {
"@type": "Organization",
"name": "Department of Plant, Soil and Microbial Sciences, Michigan State University, East Lansing, Michigan, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Nocturnal polyuria and nocturia.",
"datePublished": "2023-03-31",
"url": "https://questionsmedicales.fr/article/37000379",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11255-023-03582-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "The patient burden of nocturnal polyuria in the United States: Results from the epidemiology of nocturnal polyuria (EpiNP) study.",
"datePublished": "2023-01-19",
"url": "https://questionsmedicales.fr/article/36655731",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/nau.25126"
}
},
{
"@type": "ScholarlyArticle",
"name": "[A female patient with earache, polyuria and polydipsia].",
"datePublished": "2022-07-04",
"url": "https://questionsmedicales.fr/article/35785784",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/a-1869-0732"
}
},
{
"@type": "ScholarlyArticle",
"name": "Nocturnal polyuria in women: results from the EpiNP study.",
"datePublished": "2023-01-28",
"url": "https://questionsmedicales.fr/article/36708403",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00192-022-05432-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Nocturia due to nocturnal polyuria (NP). A common disorder.",
"datePublished": "2022-09-26",
"url": "https://questionsmedicales.fr/article/36165487",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.4081/aiua.2022.3.366"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines et peptides de signalisation intracellulaire",
"item": "https://questionsmedicales.fr/mesh/D047908"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protein-Serine-Threonine Kinases",
"item": "https://questionsmedicales.fr/mesh/D017346"
},
{
"@type": "ListItem",
"position": 6,
"name": "Cyclic Nucleotide-Regulated Protein Kinases",
"item": "https://questionsmedicales.fr/mesh/D017867"
},
{
"@type": "ListItem",
"position": 7,
"name": "Cyclic GMP-Dependent Protein Kinases",
"item": "https://questionsmedicales.fr/mesh/D017869"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Cyclic GMP-Dependent Protein Kinases - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Cyclic GMP-Dependent Protein Kinases",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-17",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Cyclic GMP-Dependent Protein Kinases",
"description": "Comment diagnostiquer une dysfonction des kinases cGMP ?\nQuels tests sont utilisés pour mesurer le cGMP ?\nQuels symptômes indiquent un problème avec les kinases cGMP ?\nLes tests génétiques sont-ils utiles pour les kinases cGMP ?\nComment évaluer l'activité des kinases cGMP ?",
"url": "https://questionsmedicales.fr/mesh/D017869?mesh_terms=Polyuria#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Cyclic GMP-Dependent Protein Kinases",
"description": "Quels sont les symptômes d'une déficience en kinases cGMP ?\nLes troubles neurologiques sont-ils liés aux kinases cGMP ?\nComment les kinases cGMP affectent-elles la fonction cardiaque ?\nY a-t-il des symptômes spécifiques aux maladies liées aux kinases cGMP ?\nLes troubles de l'humeur peuvent-ils être liés aux kinases cGMP ?",
"url": "https://questionsmedicales.fr/mesh/D017869?mesh_terms=Polyuria#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Cyclic GMP-Dependent Protein Kinases",
"description": "Comment prévenir les troubles liés aux kinases cGMP ?\nL'alimentation influence-t-elle les kinases cGMP ?\nLe stress a-t-il un impact sur les kinases cGMP ?\nLes examens réguliers sont-ils importants ?\nL'exercice physique aide-t-il à la prévention ?",
"url": "https://questionsmedicales.fr/mesh/D017869?mesh_terms=Polyuria#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Cyclic GMP-Dependent Protein Kinases",
"description": "Quels traitements ciblent les kinases cGMP ?\nLes médicaments augmentant le cGMP sont-ils efficaces ?\nComment les thérapies géniques peuvent-elles aider ?\nY a-t-il des traitements naturels pour les dysfonctionnements cGMP ?\nLes changements de mode de vie peuvent-ils aider ?",
"url": "https://questionsmedicales.fr/mesh/D017869?mesh_terms=Polyuria#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Cyclic GMP-Dependent Protein Kinases",
"description": "Quelles complications peuvent survenir avec des dysfonctionnements cGMP ?\nLes troubles de la coagulation sont-ils liés aux kinases cGMP ?\nY a-t-il des risques de cancer associés aux kinases cGMP ?\nLes maladies rénales peuvent-elles être influencées par cGMP ?\nLes troubles respiratoires sont-ils liés aux kinases cGMP ?",
"url": "https://questionsmedicales.fr/mesh/D017869?mesh_terms=Polyuria#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Cyclic GMP-Dependent Protein Kinases",
"description": "Quels sont les facteurs de risque pour les dysfonctionnements cGMP ?\nL'âge influence-t-il la fonction des kinases cGMP ?\nLe mode de vie sédentaire est-il un facteur de risque ?\nLe stress chronique est-il un facteur de risque ?\nLes antécédents familiaux jouent-ils un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D017869?mesh_terms=Polyuria#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysfonction des kinases cGMP ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests biochimiques et des analyses génétiques peuvent être utilisés pour évaluer la fonction des kinases cGMP."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour mesurer le cGMP ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des dosages immunologiques et des tests enzymatiques peuvent mesurer les niveaux de cGMP dans les tissus."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un problème avec les kinases cGMP ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes variés comme des troubles cardiovasculaires ou neurologiques peuvent indiquer un dysfonctionnement."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils utiles pour les kinases cGMP ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests génétiques peuvent identifier des mutations affectant les kinases cGMP."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'activité des kinases cGMP ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'activité peut être évaluée par des essais enzymatiques spécifiques in vitro."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une déficience en kinases cGMP ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure des troubles de la circulation sanguine et des problèmes de vision."
}
},
{
"@type": "Question",
"name": "Les troubles neurologiques sont-ils liés aux kinases cGMP ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies dans les kinases cGMP peuvent contribuer à des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Comment les kinases cGMP affectent-elles la fonction cardiaque ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles régulent la relaxation et la contraction cardiaque, influençant la pression artérielle."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques aux maladies liées aux kinases cGMP ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes spécifiques peuvent inclure des douleurs thoraciques et des palpitations."
}
},
{
"@type": "Question",
"name": "Les troubles de l'humeur peuvent-ils être liés aux kinases cGMP ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des études suggèrent un lien entre les kinases cGMP et la régulation de l'humeur."
}
},
{
"@type": "Question",
"name": "Comment prévenir les troubles liés aux kinases cGMP ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir un mode de vie sain et surveiller les facteurs de risque cardiovasculaires aide à prévenir."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle les kinases cGMP ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en antioxydants peut soutenir la fonction des kinases cGMP."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur les kinases cGMP ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut affecter la signalisation cGMP et la santé cardiovasculaire."
}
},
{
"@type": "Question",
"name": "Les examens réguliers sont-ils importants ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des examens réguliers peuvent aider à détecter précocement des dysfonctionnements cGMP."
}
},
{
"@type": "Question",
"name": "L'exercice physique aide-t-il à la prévention ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut améliorer la signalisation cGMP et la santé globale."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent les kinases cGMP ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des inhibiteurs spécifiques et des modulateurs de cGMP sont utilisés pour traiter certaines conditions."
}
},
{
"@type": "Question",
"name": "Les médicaments augmentant le cGMP sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des médicaments comme les nitrates et les inhibiteurs de la phosphodiestérase peuvent être efficaces."
}
},
{
"@type": "Question",
"name": "Comment les thérapies géniques peuvent-elles aider ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les thérapies géniques peuvent corriger des mutations dans les gènes des kinases cGMP."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements naturels pour les dysfonctionnements cGMP ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines plantes médicinales peuvent avoir des effets bénéfiques sur la signalisation cGMP."
}
},
{
"@type": "Question",
"name": "Les changements de mode de vie peuvent-ils aider ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation saine et l'exercice peuvent améliorer la fonction des kinases cGMP."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des dysfonctionnements cGMP ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications peuvent inclure des maladies cardiovasculaires et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Les troubles de la coagulation sont-ils liés aux kinases cGMP ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies dans les kinases cGMP peuvent affecter la coagulation sanguine."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de cancer associés aux kinases cGMP ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent un lien entre les dysfonctionnements cGMP et le développement du cancer."
}
},
{
"@type": "Question",
"name": "Les maladies rénales peuvent-elles être influencées par cGMP ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les kinases cGMP jouent un rôle dans la régulation de la fonction rénale."
}
},
{
"@type": "Question",
"name": "Les troubles respiratoires sont-ils liés aux kinases cGMP ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies dans la signalisation cGMP peuvent contribuer à des troubles respiratoires."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les dysfonctionnements cGMP ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'hypertension, le diabète et le tabagisme."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il la fonction des kinases cGMP ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut affecter la signalisation cGMP et la santé cardiovasculaire."
}
},
{
"@type": "Question",
"name": "Le mode de vie sédentaire est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire peut augmenter le risque de dysfonctionnement des kinases cGMP."
}
},
{
"@type": "Question",
"name": "Le stress chronique est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut perturber la signalisation cGMP et augmenter les risques de maladies."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de maladies cardiovasculaires peuvent augmenter le risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 06/04/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
3 publications dans cette catégorie
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Affiliations :
Sechenov Institute of Evolutionary Physiology and Biochemistry of the Russian Academy of Sciences, Saint Petersburg 194223, Russia.
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Affiliations :
Department of Plant, Soil and Microbial Sciences, Michigan State University, East Lansing, Michigan, USA.
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Affiliations :
Department of Plant, Soil and Microbial Sciences, Michigan State University, East Lansing, Michigan, USA.
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Affiliations :
Department of Molecular and Cellular Biology, Sungkyunkwan University School of Medicine, Suwon, Republic of Korea.
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Affiliations :
Department of Veterinary Clinical Pathology and Bio-safety Research Institute, College of Veterinary Medicine, Chonbuk National University, Jeonju, Republic of Korea.
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Veterinary Internal Medicine, College of Veterinary Medicine, Seoul National University, Seoul, Republic of Korea.
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Affiliations :
Department of Molecular and Cellular Biology, Sungkyunkwan University School of Medicine, Suwon, Republic of Korea.
BK21Plus Program for 21st Century Biomedical Science Leader Development, Sungkyunkwan University School of Medicine, Suwon, Republic of Korea.
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
Nocturia is a common complaint that can have a significant impact on quality of life. The pathophysiology is usually multifactorial and can be due to poor sleep, nocturnal polyuria, or low bladder cap...
Nocturnal polyuria (NP) is the most common cause of nocturia in older adults. We hereby review the role of nocturnal polyuria in nocturia....
To manage nocturia, a multipronged approach personalized to the patient's multifactorial etiology is warranted, with a focus on lifestyle modifications and behavioral approaches as first-line therapie...
Referral to specialists in sleep or bladder-related disorders may be necessary for some patients. With comprehensive and individualized management, patients with nocturia can achieve improved quality ...
To explore the impact of nocturnal polyuria (NP) on health-related quality of life (HRQoL), work productivity, mental health, fatigue, bother, and daytime sleepiness....
This large-scale, US population-representative epidemiologic study was conducted in two parts: a web-based survey and 3-day bladder diary. Consenting participants completed the baseline Epidemiology o...
A total of 4893 men and 5297 women completed the EpiNP survey; mean age was 54.4 (SD = 14.7). Significantly greater patient burden (p < 0.0001) was evidenced in the nocturia group (≥2 voids/night) ver...
This was the first large-scale, epidemiologic study to explore the impact of different forms of NP on patients' HRQoL. Findings demonstrate that NP associated with other urologic or comorbid condition...
Langerhans cell histiocytosis is a rare inflammatory bone marrow neoplasia that frequently affects bone, lung, skin and pituitary gland. Due to its broad spectrum of clinical presentation, an appropri...
A 54-year-old female patient complained of pain in her right ear for 5 months. On account of similar complaints, a mastoidectomy had already been performed 3 years ago. Histology at that time revealed...
Computed tomography of the temporal bones showed osteolysis in the mastoid. Magnetic resonance imaging and bone scintigraphy assessed these changes as uncharacteristically inflammatory. Polydipsia pro...
Besides systemic chemotherapy with cytarabine, the patient also received denosumab and desmopressin....
Langerhans cell histiocytosis involving cranial bones is often associated with diabetes Insipidus. Knowledge about the distinctive constellation may lead to a more rapid diagnosis and improved prognos...
Data from a large US population-based, cross-sectional, epidemiological study (the EpiNP Study) were used to assess the symptoms and bother experienced by women with nocturnal polyuria (NP)....
Consenting participants recruited from an online panel completed the baseline EpiNP survey online (Lower Urinary Tract Symptoms Tool and urological comorbidities). All reporting ≥2 voids/night and a r...
A total of 5,290 women completed the baseline survey. Mean age (range) was 54.9 (30-95) years; 1,841 (34.8%) reported ≥2 nocturnal voids. The prevalence of LUTS increased across the lifespan; however,...
NP is prevalent in women with considerable bother and is often associated with other urinary symptoms. Multifactorial causes and potential treatments of NP should be considered, particularly at a late...
To the Editor, Nocturia is a significantly underestimated medical problem that affects seriously patients' quality of life, work engagement, productivity, and overall life conditions per se. Nocturia ...
Patients with lower urinary tract symptoms (LUTS) can be subcategorized into polyuria, normal or oliguria groups. Polyuria may be caused by pathologies including diabetes mellitus (DM), chronic kidney...
Two databases were retrospectively queried for men and women who filled out a lower urinary tract symptom score (LUTSS) questionnaire, 24-h bladder diary (24HBD) and were polyuric (>2.5 L/day). Patien...
Among 814 patients who completed a 24HBD, 176 had polyuria (22%). Of the patients with complete data, 7.8% had poorly-controlled DM, 3.1% had DI, 4.7% had CKD grade 3% and 84.4% had PPD. Amongst the f...
22% of patients with LUTS were found to have polyuria based on a 24HBD. Within this cohort, four sub-populations were identified as being demonstrating statistically significant differences in 24 HVV,...
We report a case of a 40-year-old woman who developed profound polyuria (>25 L urine output) immediately after initiation of venoarterial (VA) extracorporeal membrane oxygenation (ECMO). Investigation...
To investigate the quality of life (QOL) of patients with nocturia after kidney transplantation (KT) and the association between nocturnal polyuria and sleep quality....
In a cross-sectional study, a patient who consented was evaluated using the following items: international prostate symptom QOL score, nocturia-quality of life score, overactive bladder symptom score,...
Forty-three patients were included in the analysis. Approximately 25% of patients urinated once at night, and 58.1% had nocturia twice. Nocturnal polyuria was observed in 86.0% of patients, and overac...
Nocturnal polyuria, poor sleep quality, and aging may decrease the QOL of patients with nocturia after KT. Further investigations, including optimal water intake and interventions, can lead to better ...
To develop and evaluate a predictive nomogram for polyuria during general anesthesia in thoracic surgery....
A retrospective study was designed and performed. The whole dataset was used to develop the predictive nomogram and used a stepwise algorithm to screen variables. The stepwise algorithm was based on A...
The sample included 529 subjects who had undergone thoracic surgery. Fentanyl use, gender, the difference between mean arterial pressure at admission and before the operation, operation type, total am...
Individualized and precise prediction of intraoperative polyuria allows for better anesthesia management and early prevention optimization....
Central nervous system germ cell tumors (CNSGCTs) are rare neoplasms which usually develop in the midline structures. They are occasionally involved in off-midline structures of the brain. Here, we re...